JAMA DermRCT
Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus
A Randomized Clinical Trial.
ConclusionThe results of this randomized clinical trial suggest that ruxolitinib cream significantly reduced lesions and itch in patients with lichen planus. Therefore, ruxolitinib cream represents a potential treatment option for patients with cutaneous lichen planus.
Mangold AR, Lockshin B, … senior author Ehst BDJAMA Dermatology